← Back to Search

Diabetes App for Diabetes (LIVE JustICE Trial)

N/A

Recruiting

Led By Lousie Reagan, PhD

Research Sponsored by Louise Reagan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individuals will be eligible to participate if they are age 18 and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 12

Awards & highlights

LIVE JustICE Trial Summary

This trial will test the feasibility, acceptability and effects of a diabetes app. Outcomes will measure behavior change, knowledge, distress, self-care, social support and clinical results. Focus groups will be used to evaluate acceptability.

Who is the study for?

This trial is for adults aged 18 and older with Type 1 or Type 2 diabetes who have recently been released from one of five Connecticut prisons to supervised housing or parole. Participants must be able to speak and understand English.Check my eligibility

What is being tested?

The study tests the Diabetes LIVE JustICE app against enhanced education, measuring its feasibility, acceptability, and impact on diabetes management over a period of 12 weeks with assessments at start, mid-point, and end.See study design

What are the potential side effects?

Since this trial involves an educational application and enhanced education methods rather than medication or medical procedures, traditional physical side effects are not expected.

LIVE JustICE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

LIVE JustICE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Demographics

Diabetes Knowledge

Diabetes-Related Emotional Distress

+5 more

LIVE JustICE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Because eight avatars plus the educator avatar are allowed in the VE classroom at one time, we will cap enrollment for the feasibility study to allow for CHW and CDE training and the opportunity to work together during LIVE JustICE sessions. The DSMES will consist of six synchronous 1-hour education sessions and an hour support session for participants living in supervised community housing in the experimental group. We will run the six-week series sequentially a total of eleven times over 18 months. LIVE JustICE sessions will be held conveniently for participants, and days/times rotated if needed.

Group II: ControlActive Control1 Intervention

Participants randomized to the control group will receive enhanced pre-release diabetes education with registered or licensed practical nurse-delivered diabetes education about medications and insulin administration supplemented with the literacy tailored diabetes education packets used in the principal investigator's prior research.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Louise ReaganLead Sponsor

American Diabetes AssociationOTHER

139 Previous Clinical Trials

99,478 Total Patients Enrolled

Lousie Reagan, PhDPrincipal InvestigatorUniversity of Connecticut

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project currently recruiting participants?

"Yes, clinicaltrials.gov confirms that enrollment for this trial is in progress. It was first posted on April 30th 2023 and last edited September 18th 2023 with the aim of recruiting 128 people from 1 site."

Answered by AI

To what extent is the participant pool for this trial extensive?

"Affirmative. According to the information available on clinicaltrials.gov, recruitment for this medical experiment is currently under way. This trial initially opened on April 30th 2023 and was most recently updated September 18th 2023; 128 individuals need to be enlisted from a single centre."

Answered by AI

Recent research and studies

BmjJournal

Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study

Stratton, I. M. 2000. “Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study”. Bmj. BMJ. doi:10.1136/bmj.321.7258.405.

Psychological ReviewJournal

Self-efficacy: Toward a Unifying Theory of Behavioral Change.

Bandura, Albert. 1977. “Self-efficacy: Toward a Unifying Theory of Behavioral Change.”. Psychological Review. American Psychological Association (APA). doi:10.1037/0033-295x.84.2.191.

Health PsychologyJournal

An Information-motivation-behavioral Skills Model of Adherence to Antiretroviral Therapy.

Fisher, Jeffrey D., William A. Fisher, K. Rivet Amico, and Jennifer J. Harman. 2006. “An Information-motivation-behavioral Skills Model of Adherence to Antiretroviral Therapy.”. Health Psychology. American Psychological Association (APA). doi:10.1037/0278-6133.25.4.462.

American PsychologistJournal